Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 16841 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
MDxHealth S.A.. (2/19/19). "Press Release: MDxHealth Appoints Michael K. McGarrity as CEO. Dr. Jan Groen Continues as an Advisor to the Board". Irvine, CA & Herstal. 2019-02-19
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi 2019-02-19
Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2019-02-19
S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. 2019-02-18
Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. 2019-02-18
Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & 2019-02-16
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
UCB S.A.. (2/15/19). "Press Release: UCB Builds on Its R&D Footprint to Form a Research Satellite Facility within King’s College London". Brussels & Slough. 2019-02-15
Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. 2019-02-15
Sygnature Discovery Ltd.. (2/15/19). "Press Release: Sygnature Discovery Starts 2019 with Two Senior Appointments – Dr Allan Jordan and Ms Louisa Jordison". Nottingham. 2019-02-15
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. 2019-02-14
BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. 2019-02-14
Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. 2019-02-13
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. 2019-02-13
Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. 2019-02-12
Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. 2019-02-12
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. 2019-02-12
Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. 2019-02-11
Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. 2019-02-11
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-02-11
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". 2019-02-11
Follicum AB. (2/11/19). "Press Release: Follicum Selects Novel Peptide Drug Candidate for the Treatment of Diabetes and Protection of Beta Cells". 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
UCB S.A.. (2/11/19). "Press Release: UCB and Epilepsy Society Announce Pioneering UK Genomics R&D collaboration". Slough & Brussels. 2019-02-11
Uniqure N.V.. (2/8/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-02-08
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. 2019-02-08
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA. 2019-02-07
Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". 2019-02-07
Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. 2019-02-07
Altona Diagnostics GmbH. (2/7/19). "Press Release: Altona Diagnostics Receives CE-IVD Mark for HCV RT-PCR Test". Hamburg. 2019-02-07
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec and Galapagos Enter into Collaboration in the Field of Fibrosis". Hamburg & Mechelen. 2019-02-07
Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. 2019-02-07
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". 2019-02-06
Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. 2019-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. 2019-02-05
Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. 2019-02-05
ProteoNic Biotechnology B.V.. (2/5/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company". Leiden. 2019-02-05
MorphoSys AG. (2/5/19). "Press Release: MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.". Planegg. 2019-02-05
Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-02-05
CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. 2019-02-04
Argen-X N.V. (Argenx). (2/4/19). "Press Release: Argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology". Breda, Ghent & San Diego, CA. 2019-02-04
Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
Follicum AB. (2/4/19). "Press Release: Follicum’s New Topical Formulation of FOL-005 Results in Increased Hair Growth on a Par with Leading Commercial Product". 2019-02-04
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. 2019-02-04
ETH Zürich [Florian Meyer]. (2/4/19). "Press Release: Promoting Talents and New Ideas for Food Systems of the Future". 2019-02-04
[iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. 2019-02-01
Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". 2019-02-01
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
Bayer AG. (1/31/19). "Press Release: Bayer and Kyoto University Form Research Alliance to Discover New Treatment Approaches against Lung Diseases [Not intended for U.S. and UK Media]". Berlin. 2019-01-31
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. 2019-01-30
Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN. 2019-01-30
Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. 2019-01-30
Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. 2019-01-30
Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. 2019-01-30
Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. 2019-01-30
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". 2019-01-29
Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". 2019-01-29
BioStrata Ltd.. (1/29/19). "Press Release: BioStrata Announces New Hires to Drive Continued Growth across Its Specialist Marketing Communications Offering". Cambridge. 2019-01-29
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
CureVac AG. (1/28/19). "Press Release: CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer". Tübingen & Boston, MA. 2019-01-28
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. 2019-01-28
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX. 2019-01-25
Genomics England Ltd.. (1/25/19). "Press Release: Jonathan Symonds Appointed New Chair of Genomics England". 2019-01-25
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top